|
Index of reports
> Cases resulting in disability (5)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in disability.
Adverse event in 73 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-07-19
Patient: 73 year old male
Adverse reactions / side effects: Metastatic Neoplasm, Malaise, Restlessness, Anorexia, Blindness, Antisocial Behaviour
Adverse event resulted in: death, disablity
Suspect drug(s):
MS Contin (Morphine)
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-05-23
Patient: female
Adverse reactions / side effects: Lymphadenopathy, Pruritus, Urticaria, Scleroderma, Pharyngeal Oedema, Connective Tissue Disorder, Abscess Limb, Cutaneous Lupus Erythematosus, Ligament Injury, Pelvic Mass, Pain in Extremity, Osteomyelitis Chronic, Osteitis, Vertebral Injury, Throat Irritation, Dehydration, Lymphoma, Pharmaceutical Product Complaint, Therapeutic Agent Toxicity, Pain, Impaired Work Ability, Constipation, Nasal Oedema, Road Traffic Accident, Adrenal Insufficiency, Myocardial Infarction, Medication Residue, Dyspnoea, Joint Dislocation, Uterine Cancer, Lung Disorder, Alopecia, Memory Impairment, Syncope Vasovagal, Immune System Disorder
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
MS Contin
Dosage: 60 mg, unk
Indication: Systemic Lupus Erythematosus
MS Contin
Dosage: 100 mg, bid prn
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-05-18
Patient: female
Adverse reactions / side effects: Pruritus, Lymphadenopathy, Urticaria, Scleroderma, Pharyngeal Oedema, Connective Tissue Disorder, Abscess Limb, Cutaneous Lupus Erythematosus, Pelvic Mass, Ligament Injury, Pain in Extremity, Osteomyelitis Chronic, Osteitis, Vertebral Injury, Throat Irritation, Dehydration, Pharmaceutical Product Complaint, Lymphoma, Pain, Impaired Work Ability, Therapeutic Agent Toxicity, Constipation, Nasal Oedema, Road Traffic Accident, Adrenal Insufficiency, Myocardial Infarction, Medication Residue, Dyspnoea, Joint Dislocation, Uterine Cancer, Lung Disorder, Alopecia, Memory Impairment, Immune System Disorder, Syncope Vasovagal
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
MS Contin (Morphine)
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-16
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-12
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
|
